Unlocking Glucagon Biology to Overcome Fibrosis in MASH
Time: 1:50 pm
day: Conf Day 1 Track 2 PM
Details:
- Understanding the therapeutic benefit of glucagon-based agents on serum and hepatic lipids
- Navigating Pemvitutide Phase 2b trial data
- Analyzing the effect on inflammation, LDL cholesterol and body composition
